Nonalcoholic fatty liver disease: Synopsis of current developments

Area of Science:

• Hepatology
• Gastroenterology
• Internal Medicine

Background:

• Non-alcoholic fatty liver disease (NAFLD) is a growing cause of chronic liver disease, defined by over 5% liver fat accumulation.
• Its pathogenesis is complex, involving a multi-hit process including insulin resistance, inflammation, oxidative stress, and gut-derived endotoxemia.
• Progression from simple steatosis to non-alcoholic steatohepatitis (NASH) and cirrhosis is influenced by genetic, metabolic, and environmental factors.

Purpose of the Study:

• To review recent advances in understanding the pathogenesis, pathology, and management of NAFLD.
• To outline diagnostic criteria and histological scoring systems for NASH.
• To discuss current and investigational treatment strategies for NAFLD and associated conditions.

Main Methods:

• Comprehensive Medline search of published literature.
• Review of major conference proceedings from recent years.
• Synthesis of information on NAFLD pathogenesis, diagnosis, and management.

Main Results:

• NAFLD pathogenesis involves multiple interacting factors leading to liver damage.
• NASH diagnosis requires steatosis, ballooning, and lobular inflammation; fibrosis is not mandatory.
• Management includes addressing metabolic comorbidities, lifestyle modification, and exploring therapies like Vitamin E, pentoxifylline, and probiotics.

Conclusions:

• NAFLD is a complex condition requiring a multi-faceted approach to management.
• Lifestyle modifications and treatment of associated metabolic disorders are crucial first-line strategies.
• Further research is ongoing to identify effective therapies for NASH and prevent disease progression.